Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Lymphocyte Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005804
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Fred Hutchinson Cancer Center
Very early researchEnded earlyNCT05316116
What this trial is testing

Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)

Who this might be right for
Large Granular Lymphocyte Leukemia
H. Lee Moffitt Cancer Center and Research Institute 6
Early research (Phase 1)Study completedNCT00001015
What this trial is testing

Ribavirin in the Treatment of Patients With AIDS and AIDS-Related Problems

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 96
Not applicableStudy completedNCT07690943
What this trial is testing

Evaluation of the Safety and Efficacy of Autologous COVID-19 Antigen Specific T Cell in Prolonged SARS-CoV-2 Patients

Who this might be right for
COVID-19COVID-19 (SARS-CoV-2 Infection)
LucasBio 13
Testing effectiveness (Phase 2)Study completedNCT04556734
What this trial is testing

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 80
Early research (Phase 1)Looking for participantsNCT04691622
What this trial is testing

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

Who this might be right for
Viral InfectionHematopoietic Stem Cell Transplantation (HSCT)Primary Immunodeficiency Disorders (PID)
Children's National Research Institute 48
Early research (Phase 1)UnknownNCT01637805
What this trial is testing

Clinical Safety and Preliminary Efficacy of AAV-DC-CTL Treatment in Stage IV Gastric Cancer

Who this might be right for
Stage IV Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)Looking for participantsNCT04664179
What this trial is testing

EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

Who this might be right for
EBV-Related Hodgkin LymphomaEBV-Related Lymphoproliferative DisorderEBV Related Non-Hodgkin's Lymphoma
Baylor College of Medicine 52
Testing effectiveness (Phase 2)Looking for participantsNCT06090864
What this trial is testing

ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

Who this might be right for
Hodgkin LymphomaRelapseRefractory
UNC Lineberger Comprehensive Cancer Center 31
Early research (Phase 1)WithdrawnNCT01219907
What this trial is testing

Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerStage IV Breast Cancer
University of Washington
Early research (Phase 1)Temporarily pausedNCT00160992
What this trial is testing

Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients

Who this might be right for
Melanoma
University of Lausanne Hospitals 6
Early research (Phase 1)Ended earlyNCT01948271
What this trial is testing

Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 3
Large-scale testing (Phase 3)Study completedNCT00003938
What this trial is testing

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 115
Testing effectiveness (Phase 2)UnknownNCT00242515
What this trial is testing

T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
National University Hospital, Singapore 16
Early research (Phase 1)Active Not RecruitingNCT02869217
What this trial is testing

Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors

Who this might be right for
NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive PatientsSynovial SarcomaMelanoma+5 more
University Health Network, Toronto 22
Early research (Phase 1)Looking for participantsNCT05142189
What this trial is testing

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BioNTech SE 320
Testing effectiveness (Phase 2)UnknownNCT00306410
What this trial is testing

The Prevalence of Vitamin D Deficiency and Effects of Vitamin D Supplementation in HIV-1 Infected Patients

Who this might be right for
Vitamin D DeficiencyHIV Infections
Radboud University Medical Center 85
Early research (Phase 1)Study completedNCT01333046
What this trial is testing

Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL

Who this might be right for
Hodgkin LymphomaNon-Hodgkin LymphomaHodgkin Disease
Baylor College of Medicine 36
Testing effectiveness (Phase 2)Enrolling By InvitationNCT03393962
What this trial is testing

Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors

Who this might be right for
Ovarian Cancer
Shenzhen Geno-Immune Medical Institute 20
Not applicableWithdrawnNCT00499668
What this trial is testing

Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+5 more
Vanderbilt-Ingram Cancer Center
Next Page